Differential regulation of MRN (Mre11–Rad50–Nbs1) complex subunits and telomerase activity in cancer cells (Q34129469)

31 July 2017

title

Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells (English)

1 reference

31 July 2017

Differential regulation of MRN (Mre11–Rad50–Nbs1) complex subunits and telomerase activity in cancer cells (English)

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

16 June 2024

4

K Muniyappa

1 reference

31 July 2017

Bibha Choudhary

2

1 reference

31 July 2017

C. V. Kavitha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682289

16 June 2024

Sathees C. Raghavan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682289

16 June 2024

language of work or name

English

0 references

publication date

2 August 2010

1 reference

full work available at URL

31 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0006291X10014506?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

https://api.elsevier.com/content/article/PII:S0006291X10014506?httpAccept=text/plain

16 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Biochemical and Biophysical Research Communications

16 June 2024

published in

1 reference

31 July 2017

volume

399

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

575-580

1 reference

The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway

31 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

DNA end resection: many nucleases make light work

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Alternative lengthening of telomeres: models, mechanisms and implications

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade.

16 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres

16 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Population pharmacokinetic approach to compare oral and i.v. administration of etoposide

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

16 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs

16 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Alteration of telomeric sequences and senescence caused by mutations in RAD50 of Saccharomyces cerevisiae

16 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing

16 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Telomere maintenance is dependent on activities required for end repair of double-strand breaks

16 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.

16 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy

16 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Inhibition of telomerase activity by cisplatin in human testicular cancer cells

16 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study

16 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells

16 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

DNA damage transiently increases TRF2 mRNA expression and telomerase activity

16 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture

16 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.

16 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement

16 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

16 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2010.07.117

16 June 2024

Identifiers

1 reference

31 July 2017

1 reference